CRADA PRICING CLAUSE EXCHANGE FOR ROYALTIES ONE OPTION FOR NIH TO CONSIDER
Executive Summary
Replacing the reasonable pricing clause in future Cooperative Research & Development Agreements with royalty-based agreements should be considered by National Institutes of Health Director Harold Varmus, a panel of NIH and industry reps indicated at a CRADA forum held July 21.